Careers  |  Sign In  |  Register

Latest in Ob/Gyn

An experimental women’s libido drug, flibanserin, developed by Sprout Pharmaceuticals, has been advised for rejection by the FDA advisory panel, according to Reuters. Flibanserin is a selective serotonin reuptake inhibitor (SSRI) and was initially tested as an antidepressant. After it was found to be an...
Each week we present the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing updates in the fields of medicine and healthcare.
In a new study according to The New York Times, researchers have proposed that the immune strengthening compounds and antibodies present in breast milk might explain an association was found between a lower risk of leukemia in children who were breastfed for at least 6 months. In the study from JAMA...